GLP-1 agonist medications can change how some medicines work, and other medicines may affect how GLP-1 medications work too
At 24 weeks, participants receiving the lowest dose (1 mg) lost 7.2% of body weight, while those on 4 mg lost 12.9% of body weight on average
check pricing and refill support at Pricing / Plans
The marked reduction in DM, hypertension, and dyslipidemia prevalence observed in our cohort suggests comprehensive improvements in metabolic health following LSG in adolescents
While GLP-1 drugs like Ozempic are not yet approved for Alzheimers prevention, patients who may benefit from early discussions with a neurologist include: Adults over 50 with prediabetes or type 2 diabetes Individuals with a family history of Alzheimers or dementia Patients with obesity, insulin resistance , or metabolic syndrome Those experiencing mild cognitive impairment (MCI) or early memory concerns Our neurologists can provide personalized brain health evaluations , collaborate with primary care or endocrinology specialists, and help guide decisions around GLP-1 use and Alzheimers risk reduction